Perforating folliculitis secondary to bendamustine-rituximab chemotherapy: A case report

Perforating folliculitis secondary to bendamustine-rituximab chemotherapy: A case report

Bibliographic Details
Main Authors:	Rowan Monteiro, Ishwara Bhat, Anil Abraham, T Rajlakshmi
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2017-01-01
Series:	Indian Dermatology Online Journal
Online Access:	http://www.idoj.in/article.asp?issn=2229-5178;year=2017;volume=8;issue=4;spage=290;epage=292;aulast=Monteiro

Similar Items

Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma
by: Giulia Bega, et al.
Published: (2021-12-01)

A Case of Perforating Folliculitis in a Peritoneal Dialysis Patient
by: Glenn Goodwin, et al.
Published: (2024-01-01)

A Fatal Breakthrough COVID-19 Case Following Bendamustine-Rituximab Therapy
by: Kohei Kamegai, et al.
Published: (2022-08-01)

Serum immunoglobulin G as a discriminator of infection in follicular lymphoma patients undergoing chemotherapy with bendamustine in combination with rituximab
by: Akie Hirata, et al.
Published: (2022-12-01)

Painful, plantar nodules in cutaneous macroglobulinosis: Successful treatment with rituximab and bendamustine
by: Carmine D'Acunto, PhD, et al.
Published: (2020-10-01)

Two rare cases of bronchus‐associated lymphoid tissue lymphoma successfully treated with rituximab‐bendamustine
by: Nydia Panitz, et al.
Published: (2021-08-01)

Dasatinib-induced perforating folliculitis in a bone marrow transplant patient
by: Nagendran Prabhakaran, et al.
Published: (2020-01-01)

An unusual case of primary hepatic lymphoma with dramatic but unsustained response to bendamustine plus rituximab and literature review
by: Sih-Han Liao, et al.
Published: (2017-05-01)

Idelalisib in Combination With Rituximab or Bendamustine or Both in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
by: Steven E. Coutre, et al.
Published: (2018-06-01)

Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives
by: Won Sriwijitalai, et al.
Published: (2019-02-01)

Paraneoplastic acute fibrinous and organizing pneumonia from lymphoma completely responding to bendamustine‐rituximab
by: Thomas Crowhurst, et al.
Published: (2020-12-01)

Rituximab/bendamustine/cytarabine for transplant‐eligible patients with mantle cell lymphoma: A retrospective study
by: Yuki Shimizu, et al.
Published: (2023-06-01)

Early Direct Antiglobulin Test Negativity after Bendamustine and Rituximab Treatment in Chronic Lymphocytic Leukemia: Two Cases
by: Rafet Eren, et al.
Published: (2018-11-01)

Folliculitis decalvans managed with adalimumab: A case report
by: Adel Alsantali, et al.
Published: (2023-12-01)

Management of folliculitis decalvans with ayurveda- A case report
by: Shankar Gautam, et al.
Published: (2022-10-01)

Combination of bendamustine and rituximab in the management of relapsed and refractory chronic lymphocytic leukemia: the results of retrospective study
by: S. V. Semochkin, et al.
Published: (2015-06-01)

Combination of bendamustine and rituximab in the management of relapsed and refractory chronic lymphocytic leukemia: the results of retrospective study
by: S. V. Semochkin, et al.
Published: (2015-06-01)

Dermoscopy of viral folliculitis of the beard: report of two cases
by: Biswanath Behera, et al.
Published: (2022-05-01)

Successful Treatment of Factor X Deficiency in a Patient with Lymphoplasmacytic Lymphoma with Bendamustine Plus Rituximab Regimen: A Case Report and Literature Review
by: Rungjirajittranon T, et al.
Published: (2021-10-01)

P1159: A MULTICENTER, INTERNATIONAL COLLABORATIVE STUDY EVALUATING FRONTLINE THERAPY WITH BENDAMUSTINE RITUXIMAB FOR WALDENSTRÖM MACROGLOBULINEMIA
by: S. Zanwar, et al.
Published: (2022-06-01)

Severe Liver Damage and Nonallergic Bronchitis with Eosinophilia in a Patient with Follicular Lymphoma Treated with Bendamustine plus Rituximab
by: Tatsuro Jo, et al.
Published: (2014-07-01)

Profile of Malassezia Folliculitis
by: Dwi Nurwulan Pravitasari, et al.
Published: (2016-03-01)

MALLASEZIA FOLLICULITIS ON THE NECK
by: Brzeziński Piotr, et al.
Published: (2010-10-01)

Exuberant tufted folliculitis
by: Paulo Müller Ramos, et al.
Published: (2019-02-01)

Pseudolymphomatous Folliculitis on the Nose
by: Aya Kakizaki, et al.
Published: (2012-01-01)

Pruritic folliculitis of pregnancy
by: Lilian Mathias Delorenze, et al.
Published: (2016-10-01)

An atypical case of eosinophilic pustular folliculitis with associated secondary follicular mucinosis treated with indomethacin
by: Garett J. Grant, BS, et al.
Published: (2023-04-01)

Folliculitis Decalvans and Lichen Planopilaris Phenotypic Spectrum: A Case Report
by: Zhang X, et al.
Published: (2022-05-01)

Eosinophilic pustular folliculitis (EPF): a case report and literature review
by: N Cherdpongtakit, et al.
Published: (2008-04-01)

Folliculitis Keloidalis Nuchae - Clinical Mimic of Malignancy: A Case Report
by: S V Poflee, et al.
Published: (2018-08-01)

Scalp Pemphigus Vulgaris Mimicking Folliculitis Decalvans: A Case Report
by: Manal Bosseila, et al.
Published: (2019-07-01)

Immune recovery folliculitis: Case reports in HIV naïve and experienced patients
by: Marta Camici, et al.
Published: (2021-01-01)

Efficacy of a bendamustine and rituximab combination in first-line therapy for chronic lymphocytic leukemia: Results of the BEN-001 study
by: E A Stadnik, et al.
Published: (2017-07-01)

Gastrointestinal Perforation after Rituximab Therapy in Mantle Cell Lymphoma: A Case Report
by: Michael Adashek, et al.
Published: (2018-11-01)

Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region
by: Francesco Autore, et al.
Published: (2020-06-01)

First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA Trial
by: Friederike Braulke, et al.
Published: (2022-12-01)

Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax
by: Vincenzo Maria Perriello, et al.
Published: (2023-05-01)

Classic Hodgkin Lymphoproliferative Diseases Clonally Unrelated to B-Chronic Lymphocytic Leukemia Successfully Treated with Bendamustine Plus Rituximab
by: Shinya Rai, et al.
Published: (2018-09-01)

Severe CMV infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in an old mantle cell lymphoma patient
by: Gabriele Magliano, et al.
Published: (2021-08-01)

DISSEMINATE AND RECURRENT INFUNDIBULO-FOLLICULITIS
by: Lever, L, et al.
Published: (1985)